In lung cancer cells, CPT exhibits antitumor effects by inhibiting cell proliferation and migration through inhibition of insulin-like growth factor-I (IGF-1)R-mediated phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway (Zhang et al., 2018a). This evidence concerns the gene AKT1 and lung cancer.